ABSTRACT
Systemic lupus erythematosus (SLE) is a multisystem disease in which dysfunctional immune regulation results in autoantibody production, immune complex formation, and activation of inflammatory cytokine pathways with subsequent tissue injury and disease manifestations. Although the etiology of SLE remains enigmatic, it is likely that antibodies to DNA are an integral component of the disease process (1).
